WEBINARS AND VIDEOS

• Future Proof Process Design Through Risk-Focused Decisions, Automation Readiness, And Regulatory Pragmatism

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene share that future proofing begins with deep process understanding.

• Streamlining Tech Transfer And Advancing Next Generation CAR T Therapies

  In this final segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene, Luman emphasizes that early engagement between R&D, process development, and manufacturing teams is critical for smooth tech transfer to CDMOs, including using scale-down models, documenting processes thoroughly, and collaborating closely with CDMO staff.

• Balancing Innovation And Flexibility In Early Cell Therapy Manufacturing Technologies

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene, Luman explains that introducing advanced analytics, automation, and digital tools early can strengthen process control and sterility, but startups must weigh innovation against practical constraints.

• The Importance Of Early Manufacturing Choices And Simple Flexible Process Design

  In this first segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene explore how early manufacturing decisions influence long-term success in cell therapy development.

• Why Academic Centers Reach The Clinic Faster

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene, Luman explains that academic institutions often move faster in Phase 1 because many trials are investigator-initiated, allowing streamlined oversight and quicker regulatory engagement, though similar pathways for sponsor-led programs don’t yet exist in the U.S. or EU.

• Early Development Choices Define Scalability And Product Quality In CGT

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene stress that early-stage process decisions have lasting downstream effects on product quality, scalability, and speed to clinic.

• Building Strong Data Foundations And Smart Logistics For Scalable CGT Development

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene emphasize that early investment in analytics and structured data collection is essential to guide scale-up and regulatory success. 

• Supply Resiliency For Bioprocessing Amid Global Volatility

  Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.

• Streamlining Vaccine Purification: Techniques For Modern Modalities

  Explore cutting-edge chromatography techniques accelerating vaccine purification across diverse modalities, with case studies on HPV, Malaria, and COVID-19.

• Scaling Plasmid DNA Production: A Proven Strategy For Higher Yields

  Learn how an agile manufacturing partner scaled their plasmid DNA production and achieved higher yields by optimizing their media selection and fermentation processes.

• Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration

  Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.

• Discover The Benchtop DynaDrive Single-Use Bioreactor

  Ready to transform your process development? Introducing the 5 L Thermo Scientific DynaDrive Single‑Use Bioreactor (S.U.B.), now available! Experience the same bioreactor design from bench to commercial and re‑imagine scalability in process development.

• Efficient Scale-Up Of Monoclonal Antibody Production: From Bench Top To 500L

  Scaling monoclonal antibody production from the lab to a commercial scale can be challenging. Learn about an approach that helps you maintain consistent productivity and product quality across all scales.

• Achieving High Purity In Complex Antibody Formats

  Discover innovative purification strategies and workflow designs for next-generation antibody formats and learn to overcome challenges in achieving high purity and yield.

• Enhancing Protein Quality Through Optimized Galactosylation

  Advance your understanding of critical protein engineering. Explore expert strategies for optimizing complex molecular structures, paving the way for more effective and consistent biological products.

• Global Strategies For Resilience And Redundancy In Cell Culture Media Supply

  Ensure your cell culture media supply remains uninterrupted. Explore proactive strategies for global manufacturing equivalency and consistent media delivery.

• Tackling Residual DNA Testing In Biotherapy Manufacturing

  Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.

• Expanding Manufacturing Of Purification Resins To Align With Customer Demands

  Discover how scaling up processes and building out facilities has allowed for end-to-end solutions that meet customer requirements for both supply and quality in their production lines.

• Ensuring Quality, Driving Customer Confidence

  How does quality assurance help drive scientific progress? A 30-year veteran shares her story of supporting customer needs and the development of groundbreaking new therapeutics.

• An Innovative Approach To High Aggregate Challenges

  In this webinar, hear from a technical specialist on addressing the challenges with antibody aggregates and process related impurity removal using a new high performance chromatography resins

• Enhancing Aseptic Fill-Finish Processes

  Achieve exceptional product recovery and sterility. Learn about high-integrity surge bags, advanced leak detection, and flexible design options for your fill-finish applications.

• CAR-T Innovation: Balancing Allogeneic And Autologous Cell Therapy

  Join experts as they discuss strategies for optimizing allogeneic and autologous therapies, aiming for balanced development and wider patient accessibility by 2030.

• Efficient AAV Purification With AAVx And AAV9 Magnetic Beads

  Explore an alternative to chromatographic affinity capture that eliminates the need for universal nuclease treatment by utilizing magnetic beads with ligands specific to AAV.

• Efficient-Pro Medium And Feed (Why Choose Pro)

  Discover an animal-origin-free and chemically defined medium and feed system solution designed to revolutionize your workflow.

• Advancing Vaccine Development With Novel Chromatography Solutions & Quality Testing

  Learn more on novel chromatography solutions that can help improve the downstream processes of different vaccine types such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).

• Scalable Purification Of In Vitro Transcribed mRNA

  Learn more about how affinity-based mRNA chromatography resin facilitates the purification and isolation of mRNA from in vitro transcription (IVT) manufacturing processes.

• Manufacturing Considerations For Viral & Non-Viral Platform Selection

  In this webinar, a panel of experts spanning the lentiviral vector, exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.

• Leveraging Rapid Sterility Testing To Advance Cell Therapy Production

  Explore the crucial role of rapid sterility testing in cell therapy manufacturing. This presentation delves into the benefits of swift, accurate detection for product quality and patient safety.

• Multi-Omics And Bioinformatics In Cell Culture Media Design

  Learn about the impact of a multi-omics analysis, utilizing proteomics and metabolomics, in the development and optimization of media with the goal of improving titer, and making development and manufacturing more efficient.

• Supporting Efficacy And Scaling With A Next-Generation T Cell AOF Formulation Medium

  Explore a novel, next-generation medium designed with an animal component-free formulation to boost therapeutic potential and enable reproducible T cells.

• Bioprocessing Solutions For Cell Culture

  Whatever the scope of your project, you can choose from our unmatched portfolio of high-impact produCTS and services to deliver consistent, scalable solutions.

• Affinity Resins Overview

  We have developed a unique portfolio of affinity resins to help you develop biosimilars, biobetters, and other types of recombinant proteins. These affinity resins can be used for clinical and commercial production.

• Development Of A CHO Medium And Feed System Using Advanced Analytical Tools And Workflow Considerations

  Discover how multiomics analysis and optimized formulations in a new cell culture medium deliver higher protein titers and specific productivity for CHO fed-batch systems.

• DoE Methodology For Downstream Purification Of pDNA Of IEX Resins

  Learn a systematic approach using Design of Experiment to optimize plasmid DNA purification. See how anion exchange resins are evaluated to enhance dynamic binding capacity and process efficiency.

• mRNA-Based Therapeutics Development Through Efficient mRNA Purification

  Discover how a novel affinity resin simplifies and maximizes the purification of mRNA therapeutics. Learn about the scalable technique vital for commercial manufacturing.

• A Straightforward Path Toward Regulatory Compliance, Data Integrity, And Computer Systems Validation

  Learn practical strategies for validating microbial identification systems in cGMP. Understand regulatory guidance and master a complete Computer Systems Validation plan for full compliance.

• Supporting Development Of mRNA Therapeutics By Enabling Commercial-Scale mRNA Purification

  Discover the next generation of scalable affinity capture for high-quality mRNA purification. Learn how a simple, reliable binding mechanism can maximize efficiency and simplify your manufacturing process.

• Microbial Identification Via DNA-Seq

  Learn how DNA sequencing-based microbial identification supports regulatory compliance and enhances contamination control in critical environments.

• BPI Interviews Purification And Pharma Analytics Leader

  Jean Luo, VP of Purification and Pharma Analytics, discusses innovations in bioprocessing, including the development of dPCR assays, lentiviral titer systems, chromatography resins, and supply chain.

• CTS DynaCellect Fluidics Demonstration

  Streamline and customize your cell processing workflow with automated, precise control over fluid movement and transfer parameters.

• Advancing The Purification Of VSV-G Pseudotyped Lentiviral Vector

  Discover new strategies to overcome lentiviral purification challenges with a scalable approach that maintains viral infectivity through gentle processing conditions.

• AAV Purification: Solving Downstream Challenges

  In this roundtable discussion, a trio of distinguished experts in AAV purification and process development share their expertise and best practices in tackling and solving downstream challenges.

• Knowledge Culture Basics — Gene Therapy Education Series: Lentiviral Vectors

  In this session of our ongoing education series on lentiviral vectors, we delve further into principles of lentiviral transduction and challenges in suspension-based lentivirus production.

• Validation Of A qPCR Assay For Host Cell DNA Quantitation

  Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.

• Uninstalling CTS Dynacellect Bead Removal Kit

  A detailed walkthrough on how to uninstall the Gibco CTS DynaCellect Bead Removal Kit when the bead removal protocol or the Gibco CTS DynaCellect magnetic separation system is completed.

• Advances In Microbial Fermentation Knowledge Culture

  Presented by three experts, this session examines real-world examples of how different approaches to media formulation and process conditions can influence outcomes.

• Advanced Contamination Control: Automation, Assays, Process Efficiency

  Learn how automated closed systems and larger bioprocess containers contribute to maintaining product integrity and how rapid analytical assays can offer reliable and accurate contamination detection.

• Accelerating Cell Culture Media Manufacturing: From Rapid Prototyping Through cGMP

  Industry leaders addressing effective ways to help streamline media manufacturing, including rapid small scale non-cGMP media prototyping and proprietary media formulation outsourcing options.

• Driving The Expansion Of mRNA Into The Therapeutic Sphere

  Discover the next wave of mRNA therapeutics and how emerging technologies are solving key challenges in downstream processing and analysis to enhance both safety and efficacy.

• Streamlining Vaccine Development, Production With Modality-Specific Purification Tools

  Novel vaccine purification tools are speeding up development for mRNA, viral vectors, and VLPs. Learn how specific chromatography resins can enhance rapid screening and downstream processing.